Cargando…
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
Autores principales: | Habtemariam, Solomon, Nabavi, Seyed Fazel, Ghavami, Saeid, Cismaru, Cosmin Andrei, Berindan-Neagoe, Ioana, Nabavi, Seyed Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192109/ https://www.ncbi.nlm.nih.gov/pubmed/32360584 http://dx.doi.org/10.1016/j.phrs.2020.104853 |
Ejemplares similares
-
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell
por: Nabavi, Seyed Fazel, et al.
Publicado: (2021) -
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020) -
COVID-19 and antimalarials. Have we been doing it wrong all along?
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2021) -
Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020)